SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-058322
Filing Date
2015-08-10
Accepted
2015-08-10 17:13:44
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-12009_110q.htm 10-Q 1099626
2 EX-31.1 a15-12009_1ex31d1.htm EX-31.1 11179
3 EX-31.2 a15-12009_1ex31d2.htm EX-31.2 11006
4 EX-32.1 a15-12009_1ex32d1.htm EX-32.1 5023
5 EX-32.2 a15-12009_1ex32d2.htm EX-32.2 5034
  Complete submission text file 0001104659-15-058322.txt   5258595

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stml-20150630.xml EX-101.INS 1258904
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20150630.xsd EX-101.SCH 39102
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20150630_cal.xml EX-101.CAL 39324
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20150630_def.xml EX-101.DEF 114456
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20150630_lab.xml EX-101.LAB 381330
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20150630_pre.xml EX-101.PRE 254286
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35619 | Film No.: 151041708
SIC: 2834 Pharmaceutical Preparations